Content from the Duke Office of Clinical Research is now live on myRESEARCHpath! Please look there for the most up-to-date information there, as content related to clinical research will soon be removed from our website.
DOCR policies are posted behind the Duke firewall and only accessible after providing a username and password and/or logging in through VPN. If you are Duke personnel and are unable to access one of these documents, please send an email to email@example.com for assistance.
Duke Office of Clinical Research Policy and Procedure Definitions (04/12/2021) - This policy defines the terms used in the clinical research policies and procedures developed by the Duke Office of Clinical Research (DOCR).
Clinical Research Unit (CRU) Policies
Annual Performance Evaluation of Clinical Research Personnel (6/15/2021) - This policy provides the standards for CRUs as it relates to the direct reporting requirements of Clinical Research Coordinators (CRCs) and research personnel performing the CRC role to the Research Practice Manager (RPM).
- Memo from Dean Andrews on the organizational minimum standards for Clinical Research Units (CRUs)
- Performance Evaluation and Planning (PEP) Form
- Procedure: CRU Guidance for Annual Performance Evaluation of Clinical Research Personnel
Clinical Research Unit (CRU) Creation (8/19/2020) - This policy describes the process of Clinical Research Unit (CRU) creation.
Clinical Research Unit (CRU) Dissolution (8/19/2020) - This policy describes the process of dissolving a Clinical Research Unit (CRU).
Clinical Research Unit Structure and Organization (3/06/2020) - This policy provides an overview for the structure and organization of clinical research for Duke Medicine (defined as the integration of Duke University Health System, Duke School of Medicine, and Duke School of Nursing).
- CRU Charter Template (05/12/2021)--This document provides a template that CRUs can use when drafting a charter
Scientific Review of New Clinical Research Proposals (1/2/2019) - This policy outlines the standards of Clinical Research Unit (CRU) review of new clinical research proposals.
Scope of Oversight and Responsibility of Clinical Research (4/06/2021) - This policy defines the scope of clinical research that is managed through Clinical Research Units and the responsibilities each CRU has for oversight of those projects.
- Additional document(s) to this policy: Fee Schedule for Other Research Projects Needing Alignment and Services (posted: 05/01/2010)
Study Start-Up Policies
Baccalaureate of Nursing for Research Staff (6/15/2021) - In order to advance the educational level of clinical research nurse coordinator (CRNC) and clinical research nurse coordinator, senior (CRNC, Sr.) registered nurses working in the Schools of Medicine and Nursing, a policy has been instituted requiring employees in these classifications have a baccalaureate degree. This policy is aligned with the DUHS strategy that has already been implemented. Please open the file to read the entire policy.
Clinical Trials Disclosure (1/21/2019) - This policy establishes internal institutional requirements to comply with federal regulations on clinical trial disclosure set forth in FDAMA and FDAAA.
Coverage Analysis (CA) and Payment of Copayments & Deductibles (06/19/2020) - This policy defines the Coverage Analysis (CA) procedure and acceptance of sponsor payments for procedures/services.
Duke Office of Clinical Research (DOCR) Effort Allocation Policy (04/13/2021) - This is the policy for allocating effort for DOCR staff.
Institutional Approval: New Clinical Research Study Initiation, Review, and Approval Standards (01/12/2021) - This policy describes the role of DOCR in the study approval process and outlines the steps necessary to obtain DOCR approval on a project.
Internal Cost Assessment (11/9/2018) - This policy outlines the process and requirements for developing an internal cost summary (determination of projected actual study costs) and what approvals will be required.
Payment Terms & Budget Policy (11/09/2018) - This policy outlines roles and responsibilities regarding payment terms and sponsor budget attachments in clinical research agreements.
Process for Adding Duke Students, Unpaid Volunteers, and Visiting Trainees/Interns to Study Personnel (03/23/2021) - The purpose of this policy is to outline the process for adding Duke students, unpaid volunteers, and visiting trainees/interns to study personnel.
Routine Costs in a Clinical Trial: NC Medicaid (03/01/2021) - This policy defines routine and qualifying trials for NC Division of Medical Assistance and describes when routine cost in a clinical trial may be charged to NC Medicaid/NC Health Choice.
Ongoing Study Management Policies
CMS Billing Regulation Regarding Healthy Volunteers - This document describes the CMS regulations regarding billing for healthy volunteers on clinical research studies.
Consent Category Requirements in iRIS and OnCore (05/25/2021) - This policy defines the requirements of Informed Consent form information needed in iRIS to ensure all IRB approved submission details transmit from iRIS to OnCore successfully
Distribution of Policies and Procedures External to Duke Medicine (01/14/2021) - This policy provides guidance to staff when an external organization or non-Duke employee has requested a DUH/DUHS/SoM policy or procedure.
Duke Box for Clinical Research Study Monitoring (03/01/2021) - This SOP clarifies the use of Duke Box when remote monitor visits are requested.
Emailing Documents to an eReg Binder (05/19/2021) - This policy defines the requirements for using the email functionality in the Advarra eRegulatory Management System (eReg).
Escalation Process for Resolution of Research Charge Reversal (01/11/2021) - This policy defines the process that research staff are required to follow when the usual reversal process for clinical research procedures billed to a participant's insurance is not resolved.
FDA and External Regulatory Agency Audits and Inspections (10/17/2019) - This policy defines Duke Medicine expectations related to audits and inspections whether they are for cause or routine.
IRB Expiration Monitoring (3/30/2018) - This policy outlines the process of monitoring IRB protocols for expiration and details the steps required in the event of a protocol approval lapse.
Monitor/Auditor Access to Maestro Care (6/26/2020) - This policy describes the process by which Duke Health facilitates remote and onsite access for research monitors/auditors when access to medical records of participants on a research protocol is needed.
On Call for Exempt Clinical Research Staff (9/11/2019) - This document standardizes the process for tracking and compensation of clinical research coordinators who provide on call support for research activities.
OnCore Documentation for Clinical Research Participants Who Provide Informed Consent (05/24/2021) - This policy defines the requirements for documenting study participation in OnCore for participants who consent to clinical research protocols approved by the DUHS IRB. Note that this policy does not apply to retrospective reviews, exempt studies, or studies using the summary accrual function in OnCore.
OnCore Minimum Footprint Report Requirements and Purpose (7/31/2020) - This policy defines the purpose of, and requirements for, the Minimum Footprint Protocol Detail Report in the OnCore application for new and modified research protocols.
Policy on Retention, Preservation and Destruction of Records - This Duke University Health System policy describes the proper way to retain records and samples obtained during research studies at Duke.
Protocol Status Update Requirements in OnCore (10/21/2020) - This policy defines the requirements for updating the protocol status in OnCore.
Remote Monitor Access to Maestro Care (4/08/2021) - This policy describes the process for requesting and granting remote access to medical records for research monitors when access is supported through an IRB-approved research protocol.
Research Requirements for DUHS Nursing Services for DEPRU and Duke Research at Pickett (R@P) (02/24/2021) - This policy describes how Duke University Health System (DUHS) nursing staff and unlicensed authorized providers (UAPs) will be managed with regard to key personnel and delegation of authority for studies done in the Duke Early Phase Research Unit (DEPRU) and Duke Research at Pickett (R@P)
- Blanket Delegation of Authority for DUHS Nursing Services for DEPRU and Duke Research at Pickett (R@P) (06/06/2021) - The purpose of this document is to describe the Blanket Delegation of Authority, which allows the PI to delegate nursing activities to DUHS nurses and UAPs providing care to research participants as referenced in the Research Requirements for DUHS Nursing Services for DEPRU and Duke Research at Pickett (R@P)
Social Security Number Exception Request Waiver for ClinCard (11/09/2018) - This policy outlines the process for Social Security Number (SSN) Exception Request waiver in the Enterprise Governance, Risk and Compliance website (eGRC) for Duke ClinCard. The Duke ClinCard system is a reloadable debit card which can be used to pay participants for their participation in clinical research.
- Template: Procedure for Using the Duke ClinCard System (11/24/2020) - This SOP Template outlines the process for using the Duke ClinCard System within a department and identifies the staff responsible for performing the roles.
Students/Residents/Fellows Leaving Duke Requiring Continued Access to Research Data (11/20/2019) - This policy outlines the process for students/residents/fellows leaving Duke requiring access to research data to support continued research activities.
Xealth for Research: Delivering Digital Study Content to Duke Health Patients (05/14/2021) - This document offers general guidelines for Duke Investigators and research teams planning to use Xealth to send digital content about a research study to potentially eligible Duke Health patients in the pre-consent period.
Study Close-Out Policies
Clinical Research Closeout Policy (11/14/2018) - This policy outlines the process and requirements for closing out a study and what approvals will be required prior to the completion of the financial closeout.
Closeout Tools: Clinical Research Tasklist (11/13/2017)
Study Closeout (9/3/2019) - This policy ensures that all research-related activities are completed and signed off prior to closing the clinical research study.
Clinical Competency for Non-Licensed Research Study Personnel Performing Vital Signs (03/15/ 2021) - This policy defines training requirements and skills necessary for non-licensed (NL) study personnel to perform clinical competencies limited to vital signs (blood pressure, pulse, temperature, pulse oximetry, respiration rate, body weight and height) for the purposes of collecting this information as required by clinical research protocols.
Collaborative Institutional Training Initiative (CITI) Module Requirements for Duke Health Human Subject Protection (HSP) (10/01/2020) - This policy describes the Human Subject Protection (HSP) certification requirements for all Duke Health clinical research personnel who interact with study participants or who have access to study participant private information.
Phlebotomy Competency Training for Research Study Personnel (10/27/2020) - This policy defines the training requirements and skills necessary to perform venipuncture/phlebotomy for the purposes of research in Duke Medicine.
Protocol Training for Clinical Research Professionals (06/14/2021) - This policy defines training requirements for clinical research personnel listed on the Delegation of Authority Log. All clinical research personnel must complete training for all tasks that are delegated to them prior to performing the task.
Duke Protected Analytics Computing Environment (PACE) Transfer Agent Policy (7/12/2018) Duke Health Policy
PACE User Attestation (1/9/2018)
REDCap Secure Usage Policy (11/14/2018) - This policy provides information about using the Research Electronic Data Capture (REDCap) system in a safe and secure manner.
Research Electronic Data Capture (REDCap) User Role Requests (11/16/2018) - This policy defines the roles and responsibilities of REDCap system users.
Use of VA Data for Research at Duke (03/16/2021) - The VA has specific data requirements for research data requests involving the use of VA data outside of the secure VA environment, when a HIPAA authorization has not been obtained. To meet VA data security requirements, Duke will maintain VA data within a FISMA moderate environment. A summary of the requirements and data solutions that Duke has implemented are found in this policy.
Maestro Care Policies
Maestro Care For Research (04/21/2021) - This policy defines the process for submission of requests for builds and/or support in Maestro Care (MC).
Placing Informed Consent Forms and Consent Process Notes in Maestro Care (06/21/2019) - This policy outlines when placement of the informed consent form and consent process note are required in MaestroCare.
Preconsent Documentation in Maestro Care (7/15/2020) - This policy describes the process for using a preconsent status in Maestro Care.
Verbal Orders Policy (2/5/2020) - This Duke Health policy describes the process for verbal orders placed in Maestro Care.
All Pickett Road Policies and Supporting Documents can be accessed here.
Care Everywhere Policies
Care Everywhere and Research (9/1/2018)
Care Everywhere Use for Research Nurses (7/19/2019) - This policy defines Care Everywhere access and its use for Research Nurses’ coordination of care of patients participating in therapeutic clinical research protocols
Workforce Engagement and Resilience Policies
Designation and Responsibilities of the SPOC (2/27/2019) - This policy identifies the RPM as the SPOC (single point of contact) for Tier Advancement and describe the duties that the SPOC is responsible for. If SPOC duties are delegated, to describe the process and necessary actions that must take place
Eligibility of Tier Advancement for Clinical Research Professional Staff (2/21/2019) - This policy defines eligibility criteria for clinical research professional staff members who apply for Tier Advancement.
DOCR provides the following procedural documents as resource for Clinical Research Units (CRUs):
Exposure Risk Determination Sheet (10/27/2017)
Forte eRegulatory (eReg) Binder Activation (5/27/2020) - This procedure oulines the necessary steps to activate an electronic regulatory binder in the Forte eRegulatory Management System (eReg).
Industry-Funded, Internally-Contracted Clinical Research Activities with No Measurable Effort (Secondary Studies) (2/1/2019) School of Medicine Finance and Resource Planning
Using Social Media to Recruit Research Participants Standard Operating Procedure (03/04/2021) - This document offers general guidelines for Duke Investigators and research teams planning to use social media to recruit human participants into research studies and trials that will be submitted to the DUHS IRB.